Applegate WB - Search Results

1

Peripheral arterial disease in randomized trial of estrogen with progestin in women with coronary heart disease: the Heart and Estrogen/Progestin Replacement Study.

Hsia J, Simon JA, Lin F, Applegate WB, Vogt MT, Hunninghake D, Carr M. Hsia J, et al. Among authors: applegate wb. Circulation. 2000 Oct 31;102(18):2228-32. doi: 10.1161/01.cir.102.18.2228. Circulation. 2000. PMID: 11056097 Clinical Trial.

2

Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudy.

Byington RP, Furberg CD, Herrington DM, Herd JA, Hunninghake D, Lowery M, Riley W, Craven T, Chaput L, Ireland CC, Applegate WB; Heart and Estrogen/Progestin Replacement Study Research Group. Byington RP, et al. Among authors: applegate wb. Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1692-7. doi: 10.1161/01.atv.0000033514.79653.04. Arterioscler Thromb Vasc Biol. 2002. PMID: 12377751 Clinical Trial.

3

Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.

Furberg CD, Adams HP Jr, Applegate WB, Byington RP, Espeland MA, Hartwell T, Hunninghake DB, Lefkowitz DS, Probstfield J, Riley WA, et al. Furberg CD, et al. Among authors: applegate wb. Circulation. 1994 Oct;90(4):1679-87. doi: 10.1161/01.cir.90.4.1679. Circulation. 1994. PMID: 7734010 Clinical Trial.

4

Effects of lovastatin and warfarin on early carotid atherosclerosis: sex-specific analyses. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.

Byington RP, Evans GW, Espeland MA, Applegate WB, Hunninghake DB, Probstfield J, Furberg CD. Byington RP, et al. Among authors: applegate wb. Circulation. 1999 Jul 20;100(3):e14-7. doi: 10.1161/01.cir.100.3.e14. Circulation. 1999. PMID: 10411862 Clinical Trial.

5

Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT).

Chesney CM, Elam MB, Herd JA, Davis KB, Garg R, Hunninghake D, Kennedy JW, Applegate WB. Chesney CM, et al. Among authors: applegate wb. Am Heart J. 2000 Oct;140(4):631-6. doi: 10.1067/mhj.2000.109648. Am Heart J. 2000. PMID: 11011338 Clinical Trial.

6

Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial disease.

Garg R, Elam MB, Crouse JR 3rd, Davis KB, Kennedy JW, Egan D, Herd JA, Hunninghake DB, Johnson WC, Kostis JB, Sheps DS, Applegate WB. Garg R, et al. Among authors: applegate wb. Am Heart J. 2000 Nov;140(5):792-803. doi: 10.1067/mhj.2000.110090. Am Heart J. 2000. PMID: 11054628 Clinical Trial.

7

Effect of pharmacologic lipid lowering on health-related quality of life in older persons: results from the Cholesterol Reduction in Seniors Program (CRISP) Pilot Study.

Santanello NC, Barber BL, Applegate WB, Elam J, Curtis C, Hunninghake DB, Gordon DJ. Santanello NC, et al. Among authors: applegate wb. J Am Geriatr Soc. 1997 Jan;45(1):8-14. doi: 10.1111/j.1532-5415.1997.tb00971.x. J Am Geriatr Soc. 1997. PMID: 8994481 Clinical Trial.

8

Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1.

Pahor M, Franse LV, Deitcher SR, Cushman WC, Johnson KC, Shorr RI, Kottke-Marchant K, Tracy RP, Somes GW, Applegate WB. Pahor M, et al. Among authors: applegate wb. Circulation. 2002 Jan 29;105(4):457-61. doi: 10.1161/hc0402.102929. Circulation. 2002. PMID: 11815428 Clinical Trial.

9

Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile.

Ferrucci L, Furberg CD, Penninx BW, DiBari M, Williamson JD, Guralnik JM, Chen JG, Applegate WB, Pahor M. Ferrucci L, et al. Among authors: applegate wb. Circulation. 2001 Oct 16;104(16):1923-6. doi: 10.1161/hc4101.097520. Circulation. 2001. PMID: 11602495 Clinical Trial.

10

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study.

Papademetriou V, Lovato L, Tsioufis C, Cushman W, Applegate WB, Mottle A, Punthakee Z, Nylen E, Doumas M; ACCORD Study Group. Papademetriou V, et al. Among authors: applegate wb. Am J Nephrol. 2017;45(2):136-145. doi: 10.1159/000453626. Epub 2016 Dec 17. Am J Nephrol. 2017. PMID: 27992863 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

239 results

Search Page